Puerto Rico

BMI View: Multinational pharmaceutical companies will open more manufacturing facilities in Foreign Trade Zones (FTZs) in Puerto Rico to benefit from the low tax rate and below-average... 2011-12-15

BMI Core View: Ensuring quality manufacturing standards is one of the fundamental responsibilities of pharmaceutical companies. Although costs will rise, we believe it necessary for... 2011-06-27

BMI View: The Central American healthcare sector's high growth forecast is driven by strong demographics, increased healthcare needs, longer life expectancy, increased healthcare spending... 2011-04-20

BMI View: The exacerbation of pressures to offset declining profits from several imminent patent expirations, coupled with the impact of the country's healthcare reform, means that... 2011-04-07

BMI View: We believe that a growing number of domestic drugmakers in Latin America will step up efforts to increase market presence in both developed and neighbouring emerging markets,... 2010-11-03

BMI View: Governments that implement policies to foster scientific innovation while offering lower operating costs will have a competitive advantage in attracting multinational drugmakers... 2010-10-29

US generic drug manufacturing and distribution company, Blu Pharmaceuticals, has opened a new production plant in Dorado, Puerto Rico. The firm is expected to invest US$60mn in the... 2010-04-19

Canadian contract drugmaker Patheon has announced that it will scale back its operations in Puerto Rico in order to cut costs. Its plant at Caguas will close and all resources will... 2009-12-14

The pending US healthcare reform has raised concerns for its unincorporated territory Puerto Rico. The current situation of underfunding in Puerto Rican healthcare coverage through... 2009-09-29

The pending US healthcare reform has raised concerns for its unincorporated territory Puerto Rico. The current situation of underfunding in Puerto Rican healthcare coverage through... 2009-09-29